Corteva (CTVA) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Q3 results reflected 20% new-product volume growth across regions and productivity gains, offset by concentrated pricing pressure and a sharper-than-expected downturn in Brazil.
FY26 adjusted pro forma Operating EBITDA guidance was reduced to $1.1B–$1.125B as Brazil’s inventory overhang and market weakness weighed on the outlook.
The Seed business separated into Vylor on Oct. 1, 2026, leaving Crop Protection as the continuing standalone business.
Financial highlights
Q3 net sales were $1.591B, down 9% reported and organically; adjusted pro forma Operating EBITDA was $222M, down 17% YoY.
9M net sales were $5.357B, down 1% reported and 4% organically; adjusted pro forma Operating EBITDA was $943M versus $937M.
Q3 adjusted pro forma Operating EPS was $0.06 versus $0.14; 9M adjusted Operating EPS was $0.76 versus $0.51.
Q3 pricing created a ~$120M EBITDA headwind; COGS productivity and lower SG&A more than offset higher R&D, producing a net $67M cost benefit.
9M EBITDA margin expanded 30 bps despite more than $230M of pricing headwinds.
Outlook and guidance
FY26 adjusted pro forma Operating EBITDA guidance is $1.1B–$1.125B, down 12% at midpoint, with margin guidance near 15%.
FY26 adjusted pro forma Operating EPS guidance is $0.76–$0.80, up 3% at midpoint; lower operating income tax expense is a supporting factor.
Guidance assumes no meaningful Brazil purchasing recovery for the rest of 2026; elevated channel inventory is expected to reduce full-year EBITDA by ~$100M.
Q4 EBITDA is expected at about half of adjusted pro forma 2025 levels; pricing is expected down high single digits, with volumes generally flat YoY.
Management expects growth in 2027, citing potential cost actions, volume recovery and easier Brazil comparisons; Crop Protection network restructuring is expected to be substantially complete in 2028.
Latest events from Corteva
- Seed-led earnings growth offset Crop Protection weakness; 2024 guidance targets further gains.CTVA
Q4 2023 - $11B innovation pipeline and operational discipline target 6% annual EBITDA growth by 2029.CTVA
Investor Day 2026 - Raised 2026 outlook after strong 1H sales, margin gains, and innovation; separation on track.CTVA
Q2 2026 - EU gene editing approval and innovation in seeds and AI set the stage for long-term growth.CTVA
Wolfe Research 3rd Annual Materials of the Future Conference 2026 - Separation on track as innovation and licensing drive growth in seed and crop protection.CTVA
21st Annual Global Farm to Market Conference - Seed strength and margin gains offset Crop Protection headwinds; 2024 outlook trimmed.CTVA
Q2 2024 - Six growth platforms and innovation target $4.4B EBITDA, 23–25% margins, and $4.5B returns by 2027.CTVA
Investor Day 2024 - 2025 outlook targets double-digit EBITDA growth and margin expansion, led by cost savings and innovation.CTVA
Q3 2024 - 2025 guidance targets 10% EBITDA growth and margin expansion amid strong segment momentum.CTVA
Q4 2024